KAZIA THERAPEUTICS-SPON ADR
KZIA · NASDAQ
Updated at 2026-10-14 09:17:16
- Today's High
- $8.94
- Today’s Low
- $8.00
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $9.05
- Previous Close
- $8.81
- Volume
- 67K
- Market Cap
- $102.04M
- P/E Ratio
- --
- EPS
- $-0.01
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- THREE INTERNATIONAL TOWERS, SYDNEY, NSW, AUSTRALIA, 2000
- Country
- AU
- Listing Date
- 1994-09-01
- Fiscal Year End
- June
- Shares Outstanding
- 5.36B
- CIK
- 0001075880
- Website
- www.kaziatherapeutics.com
Kazia Therapeutics Limited, a biotechnology company focused on oncology, develops anticancer drugs. The company is headquartered in Sydney, Australia.
Financial Metrics
Revenue
2025-12-31
--
2025-09-30
$19.71K
2024-12-31
$22.29K
2024-09-30
$2.48M
Operating Expenses
2025-12-31
$13.3M
2025-09-30
$6.46M
2024-12-31
$9.39M
2024-09-30
$22.05M
Net Income
2025-12-31
-$12.32M
2025-09-30
-$9.95M
2024-12-31
-$10.45M
2024-09-30
-$17.95M
Net Profit Margin
2025-12-31
--
2025-09-30
-50.48K%
2024-12-31
-46.89K%
2024-09-30
-723.68%
Earnings Per Share
2025-12-31
--
2025-09-30
$-7.64
2024-12-31
--
2024-09-30
$-31.22
Earnings Before Interest, Taxes, Depreciation, and Amortization
2025-12-31
-$13.3M
2025-09-30
-$4.84M
2024-12-31
-$8.9M
2024-09-30
-$18.64M
Effective Tax Rate
2025-12-31
--
2025-09-30
13.58%
2024-12-31
1.28%
2024-09-30
0.74%
| Item | 2025-12-31 | 2025-09-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | -- | $19.71K | $22.29K | $2.48M |
| Operating Expenses | $13.3M | $6.46M | $9.39M | $22.05M |
| Net Income | -$12.32M | -$9.95M | -$10.45M | -$17.95M |
| Net Profit Margin | -- | -50.48K% | -46.89K% | -723.68% |
| Earnings Per Share | -- | $-7.64 | -- | $-31.22 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$13.3M | -$4.84M | -$8.9M | -$18.64M |
| Effective Tax Rate | -- | 13.58% | 1.28% | 0.74% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.